Sangamo Therapeutics (SGMO) Other Working Capital Changes (2016 - 2025)
Sangamo Therapeutics (SGMO) has disclosed Other Working Capital Changes for 16 consecutive years, with -$4.1 million as the latest value for Q4 2025.
- For Q4 2025, Other Working Capital Changes fell 205.99% year-over-year to -$4.1 million; the TTM value through Dec 2025 reached -$830000.0, down 225.49%, while the annual FY2025 figure was -$830000.0, 225.49% down from the prior year.
- Other Working Capital Changes hit -$4.1 million in Q4 2025 for Sangamo Therapeutics, down from $5.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $149.4 million in Q4 2023 and bottomed at -$159.7 million in Q3 2023.
- Average Other Working Capital Changes over 5 years is -$5.4 million, with a median of -$996500.0 recorded in 2024.
- Year-over-year, Other Working Capital Changes crashed 11598.99% in 2022 and then skyrocketed 253.75% in 2023.
- Sangamo Therapeutics' Other Working Capital Changes stood at $58.0 million in 2021, then plummeted by 267.69% to -$97.2 million in 2022, then surged by 253.75% to $149.4 million in 2023, then plummeted by 97.44% to $3.8 million in 2024, then crashed by 205.99% to -$4.1 million in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$4.1 million, $5.5 million, and -$1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.